Scarica l'app Stockscreener
1.76
1.15%
0.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GANX Giù?
Forum
Previsione
Gain Therapeutics Inc Azioni (GANX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | -0.3052 | 0.1054 | 0.0845 |
Operating Expenses
|
16.48%
5.0895
|
4.3694 | 3.3311 | 4.459 | 8.1828 |
| Operating Income/Loss |
16.48%
-5.0895
|
-4.3694 | -3.3311 | -4.459 | -8.1828 |
| Income/Loss From Continuing Operations Before Tax |
27.96%
-5.6679
|
-4.4295 | -3.2635 | -4.4747 | -8.1419 |
| Income Tax Expense/Benefit |
40.49%
0.1412
|
0.1005 | 0.5047 | 0.011 | 0.00121 |
| Income/Loss From Continuing Operations After Tax |
28.23%
-5.8091
|
-4.5301 | -3.7682 | -4.4857 | -8.1431 |
|
Net Income/Loss
|
28.23%
-5.8091
|
-4.5301 | -3.7682 | -4.4857 | -8.1431 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5.77%
30.34
|
28.69 | 1.608 | 26.53 | 19.22 |
| Diluted Average Shares |
5.77%
30.34
|
28.69 | 1.608 | 26.53 | 19.22 |
| Basic Earnings Per Share |
18.75%
-0.19
|
-0.16 | -0.11 | -0.17 | -0.42 |
| Diluted Earnings Per Share |
18.75%
-0.19
|
-0.16 | -0.11 | -0.17 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):